Postmarketing surveillance of telaprevir-based triple therapy for chronic hepatitis C in Japan.
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2016
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2016 New trial record
- 01 Dec 2015 Interim results ( n=3563) published in the Hepatology Research.